Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Mistakes disrupt budgets and derail goals. Explore how small oversights impact finances and how to recalibrate for stable, predictable spending.
27,871 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
BitMEX co-founder Arthur Hayes signals he will not buy BTC now, citing a fragile liquidity backdrop and a need for Fe...
Uber expands its autonomous-vehicle ambitions by teaming up with Zoox, clouding the landscape with more AV partners a...
Bitcoin steadies near the $70,000 mark as oil prices leap and geopolitical tensions rise. Analysts weigh whether the ...
NFM Lending hires high-producing South Carolina loan officer Phil Crescenzo Jr., signaling a bold Southeast expansion...
Two discount retailers face off for 2026 returns, with Dollar Tree highlighting a store-format push and Dollar Genera...
A fresh look at Toyota, Brunswick, and Foresight ranks the best mobility stocks based on earnings power, cash flow, a...
General Mills sits near $39 after a soft quarter, boosting the dividend to about 6.3%. Retirees eyeing general mills’...
Mastercard broadens its Crypto Partner Program to include Ripple, prompting fresh questions about whether XRP will mo...
Zenith Labs announced a new cross-chain bridge that lets the Canton network and Ethereum swap tokens via atomic swaps...
Federal Reserve Governor Christopher Waller signaled that he does not support additional rate hikes for now and expec...
Bitcoin hovers near a critical zone as traders weigh whether a floor is forming or a deeper pullback lies ahead. ETF ...